{
  "main_header": {
    "sid": 1002850,
    "name": "Trident Texofab",
    "stock_name": "Trident Texofab",
    "full_name": "Trident Texofab Ltd",
    "name_url": "stocks-analysis/trident-texofab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "169.00",
    "chg": -5.35,
    "chgp": "-3.07%",
    "dir": -1,
    "prev_price": "174.35",
    "mcapval": "229.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540726,
    "symbol": "",
    "ind_name": "Trading",
    "ind_code": 49,
    "isin": "INE071Y01013",
    "curr_date": "Apr 11, 12:47 PM",
    "curr_time": "00:07 AM",
    "bse_nse_vol": "6.31 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trident-texofab-1002850-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Trident Texofab Reports Q3 FY24-25 Growth Amid Long-Term Challenges and Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-texofab-downgraded-to-sell-amid-weak-long-term-fundamentals-and-high-debt-ratio-925579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TridentTexofab_mojoScore_397785.png",
        "date": "2025-02-10 19:03:20",
        "description": "Trident Texofab has recently adjusted its evaluation, reflecting its current financial situation. In Q3 FY24-25, the company reported net sales of Rs 31.69 crore, but faces challenges with long-term growth and debt management. Despite these issues, it achieved a significant return over the past year."
      },
      {
        "title": "Trident Texofab Reports Q3 FY24-25 Growth Amid Long-Term Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-texofab-reports-q3-fy24-25-net-sales-of-rs-31-69-crore-profit-at-rs-1-95-crore-746413",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TridentTexofab_mojoScore_352202.png",
        "date": "2025-02-04 16:55:10",
        "description": "Trident Texofab has recently adjusted its evaluation amid mixed financial performance for Q3 FY24-25. The company reported net sales of Rs 31.69 crore and a profit after tax of Rs 1.95 crore, but faces challenges with modest growth and a high debt to EBITDA ratio, alongside a decline in promoter stake."
      }
    ],
    "total": 47,
    "sid": "1002850",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/trident-texofab-1002850"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "01-Apr-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Trident Lifeline Ltd",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2025",
      "details": "Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from 01st April 2025 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Audited Standalone Financial Results for the Quarter and Year ended March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011",
      "datetime": "29-Mar-2025",
      "details": "In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations 2011 please find enclosed herewith disclosure received from Trident Lifeline Limited in terms of sub regulation (1) of said regulation.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Trident Texofab Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Jul 19",
          "dt": "2019-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Trident Texofab Ltd has announced <strong>14:10</strong> bonus issue, ex-date: 11 Aug 20",
          "dt": "2020-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Trident Texofab Reports Q3 FY24-25 Growth Amid Long-Term Challenges and Debt Concerns

2025-02-10 19:03:20

Trident Texofab has recently adjusted its evaluation, reflecting its current financial situation. In Q3 FY24-25, the company reported net sales of Rs 31.69 crore, but faces challenges with long-term growth and debt management. Despite these issues, it achieved a significant return over the past year.

Read More

Trident Texofab Reports Q3 FY24-25 Growth Amid Long-Term Financial Concerns

2025-02-04 16:55:10

Trident Texofab has recently adjusted its evaluation amid mixed financial performance for Q3 FY24-25. The company reported net sales of Rs 31.69 crore and a profit after tax of Rs 1.95 crore, but faces challenges with modest growth and a high debt to EBITDA ratio, alongside a decline in promoter stake.

Read More

View All News